Structural Characterization of Myotoxic Ecarpholin S From Echis carinatus Venom  by Zhou, Xingding et al.
Structural Characterization of Myotoxic Ecarpholin S From Echis
carinatus Venom
Xingding Zhou,* Tien-Chye Tan,* S. Valiyaveettil,y Mei Lin Go,z R. Manjunatha Kini,*
Adrian Velazquez-Campoy,§ and J. Sivaraman*
*Department of Biological Sciences, yDepartment of Chemistry, and zDepartment of Pharmacy, Faculty of Science, National University of
Singapore, Singapore 117543, Singapore; and §Institute of Biocomputation and Physics of Complex Systems, Fundacion Aragon I 1 D,
University of Zaragoza, Zaragoza 50009, Spain
ABSTRACT Phospholipase A2 (PLA2), a common toxic component of snake venom, has been implicated in various pharmaco-
logical effects. EcarpholinS, isolated from the venomof the snakeEchis carinatus sochureki, is a phospholipaseA2 (PLA2) belonging
to the Ser49-PLA2 subgroup. It has been characterized as having low enzymatic but potent myotoxic activities. The crystal structures
of native ecarpholin S and its complexes with lauric acid, and its inhibitor suramin, were elucidated. This is the ﬁrst report of the
structure of a member of the Ser49-PLA2 subgroup. We also examined interactions of ecarpholin S with phosphatidylglycerol and
lauric acid, using surface plasmon resonance, and of suramin with isothermal titration calorimetry. Most Ca21-dependent PLA2
enzymeshaveAsp inposition49,whichplaysacrucial role inCa21binding.The three-dimensional structureofecarpholinS reveals a
unique conformation of theCa21-binding loop that is not favorable forCa21 coordination. Furthermore, the endogenously bound fatty
acid (lauric acid) in the hydrophobic channel may also interrupt the catalytic cycle. These two observations may account for the low
enzymatic activity of ecarpholinS, despite full retentionof the catalyticmachinery.Theseobservationsmayalsobeapplicable toother
non-Asp49-PLA2enzymes.The interactionof suramin in its complexwithecarpholinS isquitedifferent from that reported for theLys
49-
PLA2/suramin complex, where the interfacial recognition face (i-face), C-terminal region, and N-terminal region of ecarpholin S play
important roles. This study provides signiﬁcant structural and functional insights into the myotoxic activity of ecarpholin S and, in
general, of non-Asp49-PLA2 enzymes.
INTRODUCTION
Phospholipase A2 (PLA2, enzyme classiﬁcation number 3.1.1.4)
enzymes constitute a large family of hydrolases that catalyze
the hydrolysis of the sn-2 ester bond of phospholipids, pro-
ducing free fatty acids and lysophospholipids (1–5). The PLA2
superfamily was classiﬁed into 11 groups (6). The PLA2 en-
zymes of groups I and II are major components of snake
venom in the Elapidae and Viperidae families, respectively.
Both groups exhibit Ca21-dependent enzymatic activity, with
Ca21 binding to a Ca21-binding loop and Asp49 (according to
the numbering system of Renetseder et al. (7)). Although a
majority of group II PLA2 enzymes have Asp at their position
49, this residue can occasionally be substituted with nonacidic
residues such as Lys, Ser, Asn, and Arg (8–10). As expected,
Asp49-PLA2 enzymes show high catalytic activity, whereas
non-Asp49-PLA2 enzymes show low or no enzymatic activity.
Interestingly, these non-Asp49-PLA2 enzymes exhibit strong
myotoxic activity. Extensive research has been devoted to
understanding the structure and function of Lys49-PLA2 en-
zymes. In Lys49-PLA2 enzymes, the Ne atom of Lys
49 oc-
cupies the space of the essential Ca21 ion in Asp49-PLA2
enzymes, resulting in a substantial loss of catalysis (11,12).
Furthermore, some studies suggest that a fatty-acid molecule
may lie in the hydrophobic channel, leading to the interruption
of catalytic cycles (13,14). The myotoxic/cytolytic site of
Lys49-PLA2 enzymes was identiﬁed using synthetic peptides
(15–17). Subsequent studies using inhibition by heparin,
chemical modiﬁcation, and site-directed mutagenesis strongly
supported the role of the C-terminal region in myotoxic ac-
tivity, as reviewed in detail elsewhere (18). The positively
charged patch on the surface of Lys49-PLA2 was suggested to
play an active role in myotoxic activity (19,20). Ambrosio et al.
(21) proposed that electrostatic interactions involving the
C-terminal lysine residues play a role in the insertion of the hy-
drophobic ‘‘knuckle’’ induced by Lys122 into the membrane.
So far, most of the structural and functional studies of non-
Asp49-PLA2 enzymes focused on Lys
49-PLA2 enzymes. On
the other hand, little is known about Ser49-PLA2 and other
non-Asp49-PLA2 enzymes. Here we report on the enzymatic
activity and myotoxic activity of a Ser49-PLA2 (ecarpholin S)
from the venom of the snake Echis carinatus sochureki. We
also determined crystal structures of ecarpholin S in its native
form and in complexes with lauric acid, and of its myotoxic
inhibitor, suramin. This is the ﬁrst representative structure of
the Ser49-PLA2 subgroup. Moreover, the mechanism of ac-
tion of Ser49-PLA2 is elucidated, using structural data com-
bined with biochemical and biophysical studies.
EXPERIMENTAL PROCEDURES
Materials
Ecarpholin S (belonging to the Ser49-PLA2 subgroup) was isolated from
Echis carinatus sochureki snake venom (Latoxan, Rosans, France) by fol-
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lowing the protocol of Polgar et al. (22), with minor modiﬁcations. Lyoph-
ilized venomwas dissolved at 100mg/mL in 50mMTris-HCl buffer, pH 7.0.
Soluble components were loaded onto a Superdex 200 gel-ﬁltration column
(1.0 3 60 cm, Amersham Biosciences, Uppsala, Sweden) eluted with the
same buffer. The sixth peak, estimated to have a molecular mass of ;14
kDa, was loaded onto an SP Sepharose High Performance cation-exchange
column (5 mL, Amersham Biosciences). Ecarpholin S was eluted as a main
peak from this column. We isolated ScPLA2 (belonging to the Asp
49-PLA2
subgroup) from E. c. sochureki venom according to the protocol of Jasti
et al. (23). Both isolated proteins were conﬁrmed by mass spectrometry
and N-terminal sequencing. Suramin (8,89-[carbonylbis[imino-3,1-phenyl-
enecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naph-
thalenetrisulfonic acid hexasodium), phosphatidyglycerol (from egg yolk),
and lauric acid were obtained from Sigma Chemical Co. (St. Louis, MO). All
other reagents were of analytical grade.
Phospholipase enzymatic activity
The enzymatic activity of PLA2 was measured by routine colorimetric assay,
using a 1,2-dithio analog of diheptanoylphosphatidylcholine as substrate
(PLA2 assay kit, Cayman Chemicals, Ann Arbor, MI). The ScPLA2 from E.
c. sochureki served as positive control.
Myotoxic activity
Myotoxic activity is the damage to skeletal muscle leading to the release of
cellular contents and the death of muscle cells. A number of snake venom
proteins were shown to induce myotoxicity (18). Groups of ﬁve Swiss albino
mice (18–22 g body weight) were injected (intramuscularly to the right gas-
trocnemius muscle) with 50, 75, or 100 mg of ecarpholin S in 50 mL of
phosphate-buffered saline (PBS). After 3 h, the mice were anesthetized, and
their blood was collected via heart puncture. The creatine kinase (CK) activity
of serum was then measured using a kit (No. 2910) from Stanbio Laboratory
(Boerne, Texas). One unit was deﬁned as the amount of enzyme that pro-
duces 1 mmol of NADPH/min, and activity was expressed in units/liter. In
inhibition studies, different doses of suramin were incubated with ecarpholin S
(100 mg/mouse) for 15 min at 37C before administration to animals.
Edema-inducing activity
The accumulation of ﬂuid in the interstitial space and swelling during the in-
ﬂammatory response are measured as edema. The PLA2 from snake venom is a
potent mediator of edema (5,24). The edema-inducing effects of ecarpholin S
were measured in mice, as described earlier (25). Different doses of ecarpholin
S were dissolved in 20 mL of PBS (pH 7.5) and administered via subplantar
injection into the left footpad of Swiss albino mice under anesthesia. After 1 h,
while still under anesthesia, mice were sacriﬁced by inhalation of carbon dioxide.
Both their feet (injected and uninjected) were severed just above the plantar
joint, and weighed. The percentage of edema was calculated from the differ-
ence in weight between injected and uninjected feet, with PBS as the control.
Isothermal titration calorimetry (ITC)
Ecarpholin S titrations with suramin were performed on a VP-ITC calo-
rimeter system (MicroCal LLC, Northampton, MA) at 30C. Solutions of
0.03 mM of ecarpholin S in 50 mM Tris-HCl (pH 7.4) were titrated with
0.5mM suramin dissolved in the same buffer. The reaction cell contained 1.5mL
of the protein solution in buffer. Suramin was added in 5-mL increments at 500-s
intervals. Injections of suramin solution in the same buffer, but in the absence
of protein, were used to account for the heats of mixing and dilution. Binding
parameters were estimated from isotherms obtained using scripts (Origin 7.0,
OriginLab, Northampton, Massachusetts) developed in our laboratory.
Surface plasmon resonance
Surface plasmon resonance (SPR) studies were performed with Biacore 3000
(Biacore AB, Uppsala, Sweden). We prepared phosphatidyglycerol (PG)
liposomes by sonication, as previously described (26). Brieﬂy, an appro-
priate amount of PG (2 mg) was dissolved in 2 mL of a chloroform solution,
and the organic solvent was subsequently removed by vacuum desiccation.
The resultant dried lipid ﬁlm was rehydrated with PBS (pH 7.4) at the ap-
propriate concentration at 25C for 2 h. The resulting aqueous lipid mixture
was sonicated until the solution appeared optically transparent in white light.
A homogeneous liposomal suspension of approximately uniformly sized
unilamellar vesicles with an average diameter (from dynamic light-scattering
measurement) of 456 7 nm was obtained. We performed immobilization of
the PG liposome on the L1 chip, as described by the manufacturer. Brieﬂy,
PBS (pH 6.8) was used as the running buffer, the washing solution was
40 mM N-octyl b-D-glucopyranoside, and the regenerating solution was 10
mM NaOH. Experiments were performed at 25C. Phosphatidyglycerol
unilamellar vesicles (100mL, 1 mM)were applied to the chip surface at a low
ﬂow rate (2 mL/min). To remove any multilamellar structures from the lipid
surface, we injected NaOH (50 mL, 10 mM) at a ﬂow rate of 50 mL/min,
which resulted in a stable baseline corresponding to the lipid bilayer linked to
the chip surface. The negative-control bovine serum albumin was injected
(50 mL, 0.1 mg/mL in PBS) to conﬁrm complete coverage of nonspeciﬁc
binding sites. Ecarpholin S was diluted into a suitable ﬁnal concentration,
using the running buffer. All sensorgrams were processed by using automatic
correction for nonspeciﬁc bulk refractive index effects. The equilibrium
constant (KD) was determined by the 1:1 Langmuir binding ﬁtting model
provided by the Biacore 3000 instrument software.
To study the interaction between ecarpholin S and lauric acid, ecarpholin S
was immobilized on the sensor chip CM5 (Biacore AB) by the standard pri-
mary amine-coupling reaction. The equilibration of baseline was completed by
the continuous ﬂow of HBS-EP running buffer (10 mM HEPES, 150 mM
NaCl, 3 mM EDTA, and 0.005% (v/v) surfactant P20, pH 7.4) through the
chip. One of the four serial ﬂow cells was activated for 10 min by injecting a
1:1 fresh mixture of 0.2 M 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide
(EDC) and 50 mM N-hydroxysuccinimide (NHS) at 25C. Ecarpholin S was
diluted with 10 mM HEPES buffer (pH 7.5) at a concentration of 50 mg/mL,
and immobilized to the surface of sensor chip CM5. Finally, unreacted groups
were blocked by injecting 1M ethanolamine-HCl at pH 8.5 for 7min, resulting
in immobilized densities of 3500 RU. After stabilizing the baseline, Biacore
data were collected at 25C at a constant ﬂow of 20 mL/min. Lauric acid was
diluted into a suitable ﬁnal concentration, using the running buffer. We used
70% ethanol as regeneration buffer. The equilibrium constant (KD) was de-
termined by the 1:1 Langmuir binding ﬁtting model.
Crystallization and data collection
Ecarpholin S was crystallized by hanging-drop vapor-diffusion method
using screens from Hampton Research (Aliso Viejo, CA). All crystallization
experiments were performed at room temperature, with drops containing
equal volumes (1 mL) of reservoir and protein solution. The protein was kept
in a buffer of 50 mM Tris-HCl, pH 7.4, at a concentration of 10 mg/mL. The
apo ecarpholin S crystal belonged to the space group P212121 and was grown
from a condition of 20% w/v polyethylene glycol (PEG) 3350, 20% v/v iso-
propanol, and 0.1 M sodium citrate, pH 5.6. Crystals of natural ecarpholin
S/fatty-acid complex were crystallized in the presence of 2 M ammonium sul-
fate, 0.1 M Tris-HCl, pH 8.5, and belonged to the space group P3121. Ecar-
pholin S/suramin complex crystals were obtained using 10% w/v PEG3350,
10% v/v iso-propanol, and 0.1 M sodium citrate, pH 5.6, with a molar ratio of
suramin/protein at 3:2. These crystals belonged to the space group P21. Before
the collection of x-ray diffraction data, crystals were soaked in increasing steps
of glycerol concentration (5% increase in each step; 30 min per step), and the
ﬁnal glycerol concentration was ;20% before ﬂash-freezing using liquid N2.
The x-ray diffraction data for the apo and suramin complex were collected using
an R-axis IV21 image plate detector mounted on a RU-H3RHB rotating anode
generator (RigakuCorp., Tokyo, Japan). The data for the fatty-acid complexwere
collected at the X29 beamline (National Synchrotron Light Source (NSLS),
Brookhaven National Laboratory, New York), using a Q315 CCD detector
(Area Detector Systems Corp., Poway, CA). All data sets were processed using
the HKL2000 suite (27). Crystallographic statistics are shown in Table 1.
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Structural determination and reﬁnement
Initial phases for apo ecarpholin S were obtained by the molecular replace-
ment method with Molrep (28), using the Asp49-PLA2 structure from
Agkistrodon halys Pallas as a search model (Protein Data Bank code 1JIA;
sequence identity, ;56%). The initial Rwork was 52%, and subsequent auto-
model building was performed with ARP/wARP (29). The resultant model
with the electron-density map was examined, and the model was built with
the O program (30). Structures of the lauric acid and suramin complexes were
determined using the apo ecarpholin S structure as the initial search model for
the molecular replacement method, using the program Molrep (28). Omit
maps were calculated for positioning the ligand. All three model-buildings
and reﬁnements were performed using O (30) and CNS (31) programs, with
appropriate entries in their respective dictionaries. The overall geometry of
the ﬁnal models was analyzed by PROCHECK (32). Reﬁnement statistics are
given in Table 1.
RESULTS
Characterization of ecarpholin S
Ammodytin L, the ﬁrst known Ser49-PLA2 isolated from the
snake venom of Vipera ammodytes, was initially reported to
exhibit low enzyme activity (33). However, this activity was
later attributed to contamination with ammodytoxins (34).
Polgar et al. (22) reported that Ser49-PLA2 ecarpholin S had
1.5–2.9 times more enzymatic activity than the recombinant
human group II PLA2. Our study shows that ecarpholin S has
enzymatic activity (0.1 mmol/min/mg). However, compared
with the activity of scPLA2, an Asp
49-PLA2 from the same
venom, ecarpholin S shows only 0.5% activity (24.5 mmol/
min/mg; see Fig. S1 in Supplementary Material, Data S1).
Thus it is tempting to conclude that the activity of ecarpholin
S is similar to that of some Lys49-PLA2 enzymes, which have
low catalytic ability (35–41).
Ecarpholin S is a basic PLA2 (calculated pI ¼ 8.4), with
several conserved, positively charged residues (particularly
lysine) that are thought to be important in the myotoxicity of
low molecular mass PLA2 enzymes. Hence ecarpholin S was
predicted to have myotoxic activity (22,42). Our results
conﬁrmed that ecarpholin S does exhibit myotoxic activity.
Intramuscular injections of ecarpholin S increased serum
TABLE 1 X-ray data collection and reﬁnement statistics
Apo-ecarpholin S Ecarpholin S-lauric acid complex Ecarpholin S-suramin complex
Data collection
Cell parameters (A˚) a ¼ 34.23, b ¼ 39.48, c ¼ 68.94 a ¼ b ¼ 62.09, c ¼ 124.25 a ¼ 51.45, b ¼ 132.25,
c ¼ 86.10; b ¼ 99.32
Space group P212121 P3121 P21
Molecules/asymmetry unit 1 2 8
Resolution range (A˚) 50–2.0 50–1.95 50–2.2
Wavelength (A˚) 1.5418 0.97 1.5418
Observed reﬂections 32,276 214,445 186,658
Unique reﬂections 6,463 20,851 55.923
Completeness (%) 95.7 (87.4) 99.7 (100) 97.5 (86.6)
Rsym (%)* 0.051 0.050 0.089
I/s (I) 24.7 (9.1) 21.5 (2.4) 10.8 (2.3)
Reﬁnement and quality
Resolution range (A˚) 20–2.0 30–1.95 30–2.3
Rwork (%)
y 19.2 22.8 21.7
Rfree (%)
z 25.5 26.8 27.5
rmsd bond lengths (A˚) 0.005 0.006 0.013
rmsd bond angles(deg) 1.3 1.3 1.6
Average B-factors (A˚2)§ 30.5 29.1 33.7
Main-chain 28.4 26.3 31.9
Side-chains 31.3 30.0 33.2
Waters 38.0 35.4 32.0
Lauric acid 50.2
Suramin chains 36.4
Ramachandran plot (%)
Most favored regions 90.4 89.4 85.9
Additional allowed regions 9.6 10.6 13.9
Generously allowed regions 0 0 0.1
Disallowed regions 0 0 0
Number of protein atoms 959 1918 7672
Number of ligand atoms 0 28 1031
Number of waters 96 243 370
Protein Data Bank code 2QHE 2QHD 3BJW
*Rsym ¼ +jIi  ÆIæj/+jIj, where Ii is the intensity of the ith measurement, and ÆIæ is the mean intensity for that reﬂection.
yRwork ¼ +jFobs–Fcalcj/+jFobs j, where Fcalc and Fobs are the calculated and observed structure factor amplitudes, respectively.
zRfree ¼ Rwork, but for 10% of the total reﬂections randomly selected and omitted from reﬁnement.
§Individual B-factor reﬁnement was performed.
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creatine kinase (CK) levels in a dose-dependent manner (Fig.
1). The injection of ecarpholin S at a dose of 100 mg/mouse
induced a signiﬁcant increase in serum CK activity from 160
(6 40) units/L (mean6 SD, n ¼ 5) to 1900 (6 400) units/L
(n ¼ 5), compared with physiological saline solution (PBS,
pH 7.3). Injecting ecarpholin S into the footpad of mice in-
duced mild edema. At 20 mg/mouse, ecarpholin S induced
;20% edema compared with PBS-injected control mice
(Fig. S2 in Data S1).
Structure of apo ecarpholin S
Although structures of a number of Asp49 and Lys49 PLA2
enzymes are known, to date, no structure has been available
for Ser49 PLA2 enzymes. Therefore, we determined the
structure of ecarpholin S. The structure of its apo-form was
solved by the molecular replacement method, using the
Asp49-PLA2 structure from Agkistrodon halys Pallas as a
starting model, and reﬁned to an Rwork of 19.2% (Rfree ¼
25.4%) up to 2.0-A˚ resolution. The model was reﬁned with
good stereochemical parameters (Table 1). Statistics for the
Ramachandran plot from an analysis using PROCHECK (32)
gave 90.4% of nonglycine residues in the most favored re-
gion, and no residues in the disallowed region.
The overall structure of ecarpholin S resembles that of
classic group II PLA2 enzymes. The superimposition of
ecarpholin S with a classic group II PLA2 (ScPLA2; Protein
Data Bank code 1OZ6) gave a root mean-square deviation
(rmsd) of 1.2 A˚ for 120 Ca atoms. Thus we will provide only
a general overview of the structure and the subtle differences
between ecarpholin S and other PLA2 enzymes. Ecarpholin S
consists of an N-terminal a-helix (a1), a loop equivalent to
the Ca21-binding loop, two long antiparallel a-helices (a2
and a3), the short two-stranded antiparallel b-sheet (b-wing),
and the C-terminal loop region. The sequence of ecarpholin S
contains 14 cysteine residues, forming seven disulﬁde bonds.
The pattern of disulﬁde bridges is identical to that of classic
group II PLA2 (5). Other main structural features include
highly conserved catalytic residues (His48, Tyr52, and Asp99)
and a hydrophobic channel (formed by residues such as Val2,
Leu5, Ile9, Pro18, Tyr22, and Gly30).
The Ca21-binding loop in Asp49-PLA2 is highly conserved
(Tyr28, Gly30, Gly32, and Asp49; Fig. 2). In Lys49-PLA2, the
Ne of Lys49 was shown to occupy the position of catalytically
essential calcium, and thus reduces catalytic activity (12). In
ecarpholin S, Asp49 is replaced by Ser, and Tyr28 in the Ca21-
binding loop is replaced by Phe. Although ecarpholin S
partially retains its enzymatic activity, this activity is sig-
niﬁcantly lower than that of Asp49-PLA2. Fig. 3 shows the
superimposition of the Ca21-binding loop of ecarpholin S
with scPLA2, an Asp
49-PLA2 from the same venom, and
myotoxin II, a Lys49-PLA2 from Bothrops asper venom. The
ScPLA2 is a classic Asp
49-PLA2, with Ca
21-binding at the
highly conserved Ca21-binding loop. In the case of myotoxin
II, the long side-chain of Lys49 extends into the Ca21-binding
loop and destabilizes Ca21-binding. The previous homology
modeling studies of ecarpholin S suggested that serine is a
potential candidate for replacing Asp49 without signiﬁcantly
affecting the Ca21-binding capacity (22). But this model
failed to predict the unique conformation of the Ca21-binding
loop (see below). However, in the ecarpholin S structure (Fig.
3), no calcium ion was found in the putative Ca21-binding
loop. A stretch of three residues (Gly30-Trp31-Gly32) of
ScPLA2 essentially bends to form a coordination bond with
Ca21. In the case of ecarpholin S, these three residues (Gly30-
Gly31-Gly32) are linearly extended, and cause the carbonyl O
of Gly32 to be moved away (;5 A˚) from the putative Ca21-
binding position. In addition, the whole loop moves closer to
the Ser49 residue, and the Na of Gly31 nearly occupies the
putative Ca21-binding position (1.1 A˚ away from the Gly31
N). The position of Og of Ser49 of ecarpholin S does not
occupy the position of Od of Asp49 of Asp49-PLA2 enzymes.
The side-chain of the Ser49 residue of ecarpholin S is too
short to extend into the Ca21-binding site (Og of Ser49 is 3.8
A˚ away from the putative Ca21-binding site), unlike the Ne of
Lys49 in Lys49 PLA2 (Fig. 3). Furthermore, no water mole-
cule was observed near the putative Ca21-binding site of
ecarpholin S. The nearest water molecule is;3 A˚ away from
the Ca21-binding site, and thus no alternative electron den-
sity can be modeled as Ca21. These observations strongly
suggest that the conformation of the Ca21-binding loop in
ecarpholin S is different from that of Asp49-PLA2 enzymes
and Lys49-PLA2 enzymes (Fig. 3), and the putative Ca
21-
binding loop in ecarpholin S is not favorably placed to co-
ordinate the Ca21 ion, which partially explains its lower
enzymatic activity than that of Asp49-PLA2. An attempt to
cocrystallize ecarpholin S with 100 mM calcium chloride did
not result in the incorporation of calcium ions in the Ca21-
binding loop. Binding studies using ITC showed that Ca21
did not bind to ecarpholin S (Fig. S3 in Data S1). No calcium
FIGURE 1 Effects of ecarpholin S on levels of creatine kinase (CK) in
mouse serum. Various doses of ecarpholin S (0 mg of ecarpholin S
represents 50 mL of PBS buffer), with or without suramin, were injected
into gastrocnemius muscles of mice, 3 h before their blood was collected.
Released CK in plasma was measured, and results are presented as aver-
age 6 SD (n ¼ 5).
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ion was found at the putative Ca21-binding loops of lauric
acid and suramin complexes of ecarpholin S (see below).
Thus Ser49 and the putative Ca21-binding loop of ecarpholin
S do not support the binding of Ca21 ions.
It is important to note that Ward et al. (43) carried out a
mutational study of Lys49 back to Asp, using Lys49-PLA2
bothropstoxin I. This mutant was still catalytically inactive,
demonstrating that the single Asp49 replacement with lysine
alone was not important for the lack of enzymatic activity of
this protein. Other features may also be important. In the case
of ecarpholin S, Ser49 is not ideal in terms of coordinating
with the calcium ion. Moreover, the whole Ca21-binding
loopmoves closer to the Ser49 residue, and the Gly31 N nearly
occupies the putative Ca21 binding position. In the case of
the Asp49-PLA2 subgroup, such as ScPLA2, the Tyr
28 side-
chain O hydrogen bonded with the Gly35 backbone nitrogen
atom (Fig. S4 in Data S1). In ecarpholin S, Tyr28 was re-
placed by Phe, and no hydrogen bond was observed between
Gly35 and Phe28. In the Asp49-PLA2 subgroup, Tyr
28 is
highly conserved, and this hydrogen bond appears to play an
important role in stabilizing the Ca21-binding loop. In ad-
dition, Gly33 is a highly conserved residue in Asp49-PLA2,
with a few exceptions, such as Lys33 in CRV-W6D49 from
Callosellasma rhodostoma (44), Asn33 in textilotoxin sub-
unit C, and Ser33 in the D subunit of textilotoxin from
Pseudonaja textilis (45). Interestingly, all of these exceptions
show no enzyme activity. Thus Gly33 could be another crit-
ical residue for PLA2 enzyme activity, although it is not di-
rectly involved with the coordination bonding with Ca21. In
scPLA2, Gly
30-Trp31-Gly32 bends into a loop to form coor-
dination bonds with Ca21, and Gly33 moves closer to the
Ca21 binding site. Replacing Gly33 with a residue with a side
chain, such as Lys in the case of CRV-W6D49 and Ser in
textilotoxin, could abolish the movement of these residues
toward the Ca21 binding site because of steric clashes. In
ecarpholin S, Glu33 occupies the Gly33 position. Thus we
FIGURE 2 Sequence alignment for PLA2 and chemical structure of suramin. (A) Sequence comparison of ecarpholin S and other PLA2 enzymes from snake
venom. Identical residues are in red, nonsimilar residues are in black, and conserved residues are in blue. (B) Chemical structure of suramin.
FIGURE 3 Stereo diagram of superposition of Ca21-
binding loop of PLA2 enzymes. ScPLA2 (Protein Data
Bank code, 1OZ6; blue), ecarpholin S (red), and myotoxin
II (Protein Data Bank code, 1CLP; yellow) were super-
imposed. Conformational differences of three different
Ca21-binding loops are shown. Three residues Gly30-
Trp31-Gly32 of scPLA2 bend to form a coordination bond
with Ca21, whereas three residues Gly30-Gly31-Gly32 of
ecarpholin S extend linearly, causing Gly32 carbonyl O to
move away from possible Ca21 area (;5 A˚). The whole
loop moves closer to Ser49 residue, and Na of Gly31 nearly
occupies putative Ca21-binding position (1.1 A˚ away from
Gly31 N), whereas in myotoxin II, Ne of Lys49 residue
occupies Ca21 position. The side-chain of Ser49 residue of
ecapholin S is too short to extend into Ca21-binding site
(Og of Ser49 is 3.8 A˚ away from putative Ca21-binding
site). Image was prepared using the program Pymol (59).
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speculate that the point mutation of Ser49Asp alone in ecar-
pholin S may not restore its enzyme activity.
All catalytic residues are conserved in ecarpholin S. Critical
residues of the catalytic triad of ecarpholin S (His48, Tyr52, and
Asp99) are anchored tightly to the scaffold composed of two a
helices, and superimpose with corresponding residues of two
structural homologues from Asp49 and Lys49-PLA2 enzymes
with nearly identical conformations (rmsd of 0.5 A˚) (Fig. S4 in
Data S1). The hydrophobic channel that provides access to the
catalytic site is also highly conserved. Therefore, we propose
that the nonideal conformation of the Ca21-binding loop is
responsible for the low enzyme activity of ecarpholin S.
The structure of ecarpholin S shows several positively
charged patches on the surface of the molecule (Fig. S5 in
Data S1) that may interact with negatively charged coun-
terparts on the membrane, to initiate the process of inter-
rupting the integrity of the cell. For example, a Lys49-PLA2
such as myotoxin I was shown to interrupt negatively
charged liposomes in vitro (46). To understand these inter-
actions further, we studied the binding between PG and
ecarpholin S, using SPR (Fig. 4). Phosphatidyglycerol was
immobilized to the surface of the L1 chip in the experiment,
and ecarpholin S was the analyte. Sensorgrams show that PG
binds to ecarpholin S in a dose-dependent manner. The dis-
sociation constant (KD) calculated from these sensorgrams
was 0.5 mM.
Structure of ecarpholin S/lauric acid complex
Our crystallization experiments showed that ecarpholin S
can be crystallized in different conditions. The structure
of ecarpholin S in P3121 crystal form was determined at a
1.95-A˚ resolution (Rwork ¼ 22.8%, and Rfree ¼ 26.8%). The
model was reﬁned with good stereochemical parameters
(Table 1). During structural reﬁnement, the hydrophobic
channel of ecarpholin S showed an extra electron density to
accommodate ;12 atoms. Because the crystallization con-
ditions did not contain polyethylene glycol, and considering
the extra electron density location, size, and geometry, this
electron density was modeled as lauric acid (Fig. 5 A), al-
though no lauric acid was added during the experiments.
However, no direct evidence is available to conﬁrm the
presence of lauric acid, and the assignment of the electron
density to this molecule must be regarded with caution. We
do not rule out the possibility of the binding of some other
metabolite at this site. Moreover, in the presence of isopro-
panol (10–20%) in the crystallization conditions of the apo
and suramin ecarpholin S complex (see below), no lauric acid
was evident. Probably the naturally bound lauric acid was
removed by the organic solvent present in the crystallization
conditions, whereas the lauric-acid complex was crystallized
with 2 M ammonium sulfate, and because of the high hy-
drophobic interactions, the lauric acid was retained in the
hydrophobic channel of ecarpholin S.
The lauric acid was well-deﬁned in the electron-density
map (Fig. 5 A). No calcium ion was identiﬁed at the putative
Ca21-binding loop. The overall structure of ecarpholin S in
the complex was similar to that of apo-ecarpholin S in P212121
crystal form. The bound ligand undergoes hydrophobic in-
teractions with several residues of the hydrophobic channel
such as Val2, Leu5, Gly6, Phe18, Cys45, and Tyr52. The acidic
head is stabilized by hydrogen-bonding contact with the Nd1
atom of His48, whereas the tail of the ligand extends into the
hydrophobic channel. The presence of such a natural fatty-
acid molecule was previously reported in the crystal struc-
tures of three different Lys49-PLA2 enzymes (13,14,21).
The superposition of the ecarpholin S/lauric acid complex
on the known fatty-acid complexes indicates that all ligands
are in the same region of PLA2 enzymes (Fig. 6), whereas the
conformation of the alkyl tail is different. The alkyl tail of
lauric acid of the ecarpholin S complex is close to the i-face,
whereas the tails of the other three fatty acids take different
orientations, closer to the N-terminal region. These three fatty
acids are longer, and are in generally extended conforma-
tions. The observed electron density from Fo-Fc maps and
simulated annealing omit maps did not permit us to model
our ligand with an extended conformation. The ecarpholin
S-bound lauric acid could be the result of phospholipid hy-
FIGURE 4 Studies of binding of phophatidyglycerol (PG) and lauric acid
to ecarpholin S, using SPR. Concentration-dependent binding and real-time
binding afﬁnity measurement of phophatidyglycerol (A) and lauric acid (B)
to ecarpholin S used Biacore 3000. Analyte was injected for 3 min, and
dissociation was monitored for more than 15 min. Reference and blank data
are subtracted. (A) Analyte concentrations were 20 nM, 38 nM, 75 nM, 150
nM, and 300 nM. (B) Analyte concentrations were 10 mM, 20 mM, 30 mM,
40 mM, and 50 mM.
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drolysis by ecarpholin S, followed by a failure of product
release. Alternatively, it could be a transient fatty acyl in-
termediate in the catalytic cycle that leads to the release of
fatty acid in the next step.
The Fo-Fc and omit maps of the apo and ecarpholin
S/suramin complex (see below) were carefully examined
for the presence of any PEG or fatty-acid molecules in the
hydrophobic channel, because both conditions used for
crystallization contained PEG3350. In these structures, no
electron densities could be modeled as either a fatty acid or a
PEGmolecule. It is important to note that the crystals for both
the apo-enzyme and the lauric acid complex were obtained
from the same batch of protein; the only difference involved
their crystallization conditions.
Watanabe et al. (47) obtained the MjTX-II/stearic acid
complex from a cocrystallization experiment. In the hy-
drophobic channel of MjTX-II, a second stearic acid was
observed in the vicinity of the ﬁrst stearic acid, as shown in
Fig. 6. In the case of the ecarpholin S/lauric acid complex,
no electron density was observed to model the second fatty
acid or other polymeric molecules in the corresponding
location. This result further suggests that lauric acid could
be a natural ligand for ecarpholin S, speciﬁcally binding at
one location of the hydrophobic channel. Thus, this com-
plex appears to be different from the in vitro MjTX-II/
stearic acid complex (47).
To understand these interactions further, we studied the
interaction between lauric acid and ecarpholin S, using
SPR (Fig. 4). Sensorgrams showed that lauric acid binds
to ecarpholin S in a dose-dependent manner, exhibiting
characteristic slow-binding and slow-dissociation curves.
The dissociation constant (KD) calculated from these sen-
sorgrams was 4.2 mM.
Structure of ecarpholin S/suramin complex
Suramin, a highly charged polysulfonated compound, in-
hibits the myonecrosis caused by some snake venoms and
Lys49-PLA2 enzymes (20,48–50). Similarly, suramin sig-
niﬁcantly inhibits the myotoxic activity of ecarpholin S (Fig.
FIGURE 5 Fo-Fc map shows ligand
in ecarpholin S structure. (A) Fo-Fcmap
in hydrophobic channel of ecarpholin S.
Bound lauric-acid molecules were omit-
ted before reﬁnement and map calcula-
tion. Map was contoured at a level of
2s. (B) Fo-Fc map for suramin com-
plex. Inhibitor suramin molecules were
omitted before reﬁnement and map cal-
culation. Map was contoured at a level
of 2s. All suramin molecules of asym-
metric unit have the equivalent quality
of electron density; one representative
molecule is shown here. Images were
prepared using the program Pymol (59).
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1). To understand these interactions, we determined the crys-
tal structure of the ecarpholin S/suramin complex. Data for
this complex were collected at a 2.3-A˚ resolution, and the
structure was solved and reﬁned to an Rwork of 21.7% (Rfree ¼
27.5%). The model was reﬁned with good stereochemical
parameters (Table 1). Suramin molecules were well-deﬁned
in the electron-density map (Fig. 5 B). No calcium ion was
identiﬁed at the putative Ca21-binding loop. The asymmetric
unit consists of eight ecarpholin Smonomers, with 12 suramin
molecules (3:2 inhibitor/protein ratio). The eight monomers
could be divided into four dimers, each sandwiching three
suramin molecules (Fig. 7). The conformations of all eight
monomers were nearly identical. The superimposition of apo
ecarpholin S and the ecarpholin S/suramin complex gave an
rmsd in the range of 0. 9–1.0 A˚ for all chains. Similarly, the
rmsd for the lauric-acid complex molecule A (or B) and sur-
amin complex was in the range of 0.6–0.8 A˚ for each mole-
cule. Thus, the complex formation with suramin did not result
in any signiﬁcant conformational changes in the protein.
In the ecarpholin S/suramin complex, the entrance of the
hydrophobic channel of monomers A and B of the dimer are
occupied by three suramin molecules through hydrogen-
bonding and hydrophobic interactions. Most residues that
form hydrogen bonds with suramin are located in the i-face
(Fig. 8 A). Suramin also interacts with the C-terminal region
of ecarpholin S. In addition, Asn114, Lys115, and Lys116 of
monomer A form several hydrogen-bonding contacts with
suramin (Fig. 8 B). Suramin forms interactions with the
N-terminal helix of ecarpholin S (Fig. 8C). Overall, the suramin-
recognition sites of ecarpholin S are mainly from the i-face,
C-terminal, and N-terminal regions through hydrogen-
bonding and hydrophobic interactions. In contrast, in the
Lys49-PLA2 Basp-II/suramin complex, suramin-recognition
sites are located near the putative Ca21-binding loop or on
the side of the i-face (Arg34, Lys53, and Lys69) (Figs. 7 and 8
D). In this case, suramin interacts with Basp-II, with a stoi-
chiometric ratio of 1:1. Thus, in terms of the stoichiometric
ratio and the interaction site, the ecarpholin S/suramin com-
plex is different from that of the Basp-II/suramin complex.
To test whether this observed difference is attributable to
the ratios between suramin and ecarpholin S, we crystallized
the complex at various suramin/protein ratios. The crystal
complex structure remained the same at the 3:2 ratios (in-
hibitor/protein). In all crystal structures obtained, suramin
molecules were fully occupied in all positions in the asym-
metric unit described above.We think that the surplus protein
present in the solution did not affect the crystallization of the
ecarpholin S /suramin complex.
In the crystal structure, the ecarpholin S/suramin complex
forms dimers as the minimal unit, and four dimers (octamers)
are found in the asymmetric unit. This is consistent with gel-
ﬁltration experiments. In the gel ﬁltration, the ecarpholin and
suramin mixture eluted as a dimer (Fig. 9), whereas ecar-
pholin S alone eluted as a monomer. This shows that suramin
functions as a linker molecule between the monomers, and
induces the dimerization of ecarpholin S, as revealed by the
crystal structure.
The interaction of suramin with ecarpholin S was further
examined by preliminary ITC experiments. The binding
isotherm and nonlinear least-squares analysis of the data are
shown in Fig. 10. Fig. 10, top shows the heat effect asso-
ciated with successive injections until saturation is reached.
Fig. 10, bottom shows the integrated heat effects associated
with each injection. In the analysis, the concentration of
ecarpholin S was considered on the basis of monomers. The
titration was nonmonotonic, exhibiting a biphasic shape that
does not correspond with stoichiometries for independent
binding sites. This biphasic shape is not considered an artifact,
because it always appeared and can be accounted for with
the binding model used in the analysis. Moreover, blank
titrations that injected ligand into the buffer yielded constant
heat effects.
Because the gel-ﬁltration and x-ray diffraction results
indicated that suramin promotes dimerization, and the
stoichiometry is 3:1 (suramin/dimer), the simplest way to
analyze titration is to consider a fully cooperative two-
state model in which n ligand molecules bind to a dimer
at once. Then, only two states are present: a free protein
monomer, and a dimer with n bound ligands. The chemical
equilibrium scheme for this model, as been outlined in the
Appendix, is:
2M1 nL4M2Ln; (1)
where the dimerization energetics are implicitly included in
the binding energetics, and no intermediate states appear.
Thus, the global-equilibrium constant will be a combination
of the equilibrium constant for ligand binding, KL, and the
equilibrium constant for dimerization, Kd:
FIGURE 6 Superimposition of lauric acid in hydrophobic channel of
ecarpholin S and three Lys49-PLA2 enzymes. Structure of MjTX-II/stearic
acid (Protein Data Bank code, 1XXS, red), PrTX-II/fatty acid (Protein Data
Bank code, 1QLL, blue), ACL/lauric acid (Protein Data Bank code, 1S8G,
yellow), and ecarpholin S/lauric acid (cyan) complexes were superimposed.
Lauric acid molecules are shown as lines. Image was prepared using the
program Pymol (59).
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K ¼ KLKd; (2)
and the global enthalpy will be a combination of the ligand-
binding enthalpy, DHL, and the dimerization enthalpy, DHd:
DH ¼ DHL1DHd: (3)
If it is assumed that an ecarpholin dimer binds three ligand
molecules (n¼ 3), the nonlinear analysis yields the following
values: K ¼ (2.16 0.6)3 1020 (M4), DH ¼ 276 1 kcal/
mol, N ¼ 0.69 6 0.05. The theoretical curve is able to
reproduce the experimental curve reasonably well, including
the initial part of the titration where the heat effect slightly
increases. Because the parameter N corrects for the effective
concentration of protein, there are two possible explanations
for N not being equal to unity: (1), assuming that the suramin
concentration is accurately determined, only 70% of the
protein is binding-competent; or (2), less than three suramin
molecules bind per dimer under the conditions and concen-
trations used in the ITC experiments.
If it is assumed that an ecarpholin dimer binds two ligand
molecules (n¼ 2), the nonlinear analysis yields the following
values: K ¼ (1.9 6 0.3) 3 1014 (M3), DH ¼ 26.7 6 0.8
kcal/mol, N ¼ 1.09 6 0.05. Again, the theoretical curve is
able to reproduce the experimental curve reasonably well,
including the initial part of the titration where the heat effect
slightly increases, and the ﬁt is signiﬁcantly better than the
previous one with three ligand molecules bound per dimer.
The titration experiments cannot be analyzed with a model
considering two or three independent binding sites (51), be-
cause the thermodynamic parameters obtained, and in par-
ticular the stoichiometry values, are not realistic (i.e., N
values much lower than 1).
DISCUSSION
An explanation for the mechanism of lipid hydrolysis by
Asp49-PLA2 enzymes was proposed by Verheij et al. (52),
and was subsequently modiﬁed, based on the crystal structure
of PLA2 from Naja atra venom complexed with a transition-
state analogue (53,54). In those models, the roles of active
sites, the Ca21-binding loop, the hydrophobic channel, and
the i-face were established. A structural characterization of
PLA2 isoforms with low or no enzymatic activity will help us
FIGURE 7 Stereo diagram of comparison of suramin
bound to ecarpholin S and Basp-II. (A) Three suramin
molecules are sandwiched between monomer A and mono-
mer B of ecarpholin S. (B) In Basp-II/suramin complex
(Protein Data Bank code, 1Y4L), only one suramin mole-
cule is located between the two monomers. Image was
prepared using the program Pymol (59).
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further understand the mechanism of catalysis. In a number of
group II PLA2 enzymes, one of the critical residues for Ca
21-
binding, Asp49, is replaced by nonacidic residues. As
expected, despite the conserved Ca21-binding loop, hydro-
phobic channel, and i-face, these isoforms have low or no
activity. However, crystal structures of PLA2 enzymes in
which Asp49 is replaced by nonacidic residues are not
available, with the exception of Lys49-PLA2. Hence, we in-
vestigated whether the low enzymatic activity of these PLA2
enzymes could be explained by the same factors as with
Lys49-PLA2. As shown here, the conformation of the Ca
21-
binding loop of ecarpholin S, a Ser49-PLA2, is quite different
(Fig. 6). The Asp49-PLA2 enzymes have a canonical Ca
21-
binding loop, with Ca21 in the binding pocket. In Lys49-
PLA2 enzymes, the Ne of the Lys
49 residue occupies the
position of the Ca21 ion, and displaces it. In ecarpholin S, the
putative Ca21-binding loop is distorted, and its conformation
is not suitable for calcium binding. This inability to bind
Ca21 is further supported by ITC experiments (Fig. S3 in
Data S1). This new Ca21-binding loop conformation was not
observed in any other PLA2 structures.
Although Lys49, Ser49, and other non-Asp49-PLA2 en-
zymes show limited or no enzymatic activity, they exhibit
strong myotoxic activities (including ecarpholin S). The
mechanism of their action remains interesting, because it is
believed to be independent of phospholipid hydrolysis
activity. Many proposals were put forward to explain Lys49-
PLA2 myotoxic activity, and they were summarized in re-
FIGURE 8 Comparison of interaction
region of suramin with ecarpholin S and
Basp-II. (A) Suramin interacts with
i-face region of ecarpholin S. (B) Sur-
amin interacts with C-terminal region of
ecarpholin S. (C) Suramin interacts with
N-terminal region of ecarpholin S. (D)
Suramin interacts with putative Ca21-
binding loop region of Basp-II (Protein
Data Bank code, 1Y4L). Hydrogen bonds
are shown in green (dashed lines). Images
were prepared using the program Pymol
(59).
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views (18,19). These myotoxins should have a speciﬁc
‘‘functional site’’ responsible for their potent myotoxic ac-
tivities. Synthetic peptides (KKYRYYLKPLCKK and
KKYKAYFKLKCKK) from the C-terminal region K115–
K129 of B. asper myotoxin II and A. p. piscivorus Lys49
PLA2, respectively, induce cytolytic effects and play a crit-
ical role in myotoxicity (15–17,55). This region was also
identiﬁed as a binding site for heparin (a myotoxin inhibitor)
in rat class IIA secreted PLA2 (51). Treatment with cyanogen
bromide leads to cleavage of the N-terminal octapeptide of B.
asper myotoxin II, resulting in a signiﬁcant decrease in its
membrane-damaging activities, such as liposome disruption
and myotoxicity (56–58). Thus, the N-terminal region is also
responsible for myotoxicity. The ecarpholin S/suramin
complex shows that it simultaneously binds to the C-termi-
nal, N-terminal, and i-face. These ﬁndings strongly suggest
that one or more of these three regions could be functionally
relevant regions in myotoxicity. The comparison of C-ter-
minal residues Lys115-Gly129 (KKYTYYPNFWCKG) of
ecarpholin S with the corresponding segment of B. asper
myotoxin II and A. p. piscivorus Lys49-PLA2 reveals that
they possess combinations of positively charged and hydro-
phobic residues. In the ecarpholin S/suramin complex, sur-
amin is mainly held together by a combination of both
hydrogen-bonding and hydrophobic interactions with resi-
dues, such as Lys115, Lys116, Phe124, and Trp125. Because
Lys115 and Lys116 are highly conserved among all three PLA2
enzymes, they may play a more crucial role in the activity of
myotoxic PLA2 enzymes.
Furthermore, our SPR experiments suggest that negatively
charged phospholipids, such as PG, interact with ecarpholin
S. Based on our studies, we propose a hypothesis to explain
the myotoxic activity of ecarpholin S: positively charged
residues, located in the i-face of the protein, initiate binding
with the anionic acceptor(s) (phospholipids) on the mem-
brane, leading to a further strengthening of this interaction by
hydrophobic and aromatic residues located at the entrance of
the hydrophobic channel. The C-terminal (mainly Lys115 and
Lys116) and N-terminal positive patches interact further with
the membrane, perturbing the membrane’s integrity and in-
ducing cell death. This hypothesis is highly consistent with
evidence from noncrystallographic studies involving chem-
ical modiﬁcations, synthetic peptides, inhibitors, and site-
directed mutagenesis (15–17,55–58).
Our preliminary studies to characterize the thermody-
namics of the ecarpholin/suramin interaction are in agree-
ment with suramin promoting the dimerization of ecarpholin.
The cooperative model, in which only two states are con-
sidered (free protein monomer and ligand-bound protein di-
mer), is able to describe qualitatively and quantitatively the
calorimetric titrations reasonably well. According to our re-
sults, the ecarpholin dimer might bind two suramin mole-
cules under the conditions and concentrations used for ITC
experiments. Although three suramin molecules bound to an
ecarpholin dimer are observed in the crystallographic struc-
ture, one of the three suramin molecules in every dimer has
higher a B-factor, suggesting the possibility of partial occu-
pancy. In addition, the protein and ligand concentrations are
FIGURE 9 Gel-ﬁltration studies on oligomerization of
ecarpholin S induced by suramin. (A) Elution proﬁles of
ecarpholin S without suramin. Column is Superdex 200
(Amersham Biosciences). (B) Elution proﬁles of ecarpholin
S with suramin (ecarpholin S/suramin ¼ 1:1, molar ratio).
(C) Elution proﬁles of ecarpholin S with suramin. (ecar-
pholin S/suramin ¼ 1:2, molar ratio). (D) Column cali-
brated with gel-ﬁltration standard (1.35–670 kDa from
Bio-Rad Laboratories, Hercules, California.
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signiﬁcantly higher in the crystallization setup. If two sur-
amin molecules bind to a protein dimer, the global Gibbs
energy is 19.8 kcal/mol, whereas if three suramin mole-
cules bind to a protein dimer, the global Gibbs energy is
28.2 kcal/mol. This global Gibbs energy corresponds to the
Gibbs energy for the binding of two or three ligand molecules
plus the Gibbs energy for ecarpholin dimerization. The en-
thalpy values obtained from the analysis are observed values
with a possible inﬂuence on the ionization enthalpy of the
buffer. Additional experiments would be required to assess
the extent of possible protonation events coupled to ligand
binding, and to estimate the buffer-independent binding en-
thalpies.
The fully cooperative two-state model for suramin binding
can reproduce the shape of the experimental titrations, which
supports the hypotheses that suramin promotes dimerization
and the population of ligand-free dimers is not signiﬁcant, as
observed using gel-ﬁltration chromatography. A more real-
istic model would include the ligand-free monomer-dimer
equilibrium. A more detailed discussion about the adequate
binding model would be appropriate in future work. The
inﬂuence and explicit consideration of the protein monomer-
dimer equilibrium, modulated by ligand binding, would
require additional information from ultracentrifugation ex-
periments or binding experiments at different concentrations
of protein, or by performing reverse titrations in which the
protein is injected into the ligand solution.
In conclusion, the structure of the ﬁrst representative
member of the Ser49-PLA2 subgroup of enzymes, ecarpholin
S and its complexes with fatty acid and suramin, is quite
different from the structures of Lys49-PLA2 and Asp
49-PLA2
enzymes. First, the Ca21-binding loop of ecarpholin S has a
unique conformation which is not ideal for coordinating with
Ca21. Secondly, the ecarpholin S/suramin complex shows
that, in addition to the i-face, suramin interacts with both the
C-terminal and N-terminal regions of ecarpholin S. Such
interactions were not observed in the previous report of the
Lys49-PLA2/suramin complex (20). These ﬁndings broaden
the understanding of the action of non-Asp49-PLA2 enzymes,
and should be helpful in the development of new drugs for
the treatment of myonecrosis.
APPENDIX
The procedure for the analysis of ITC experiments, according to the
cooperative model (Eq. 1), is rather straightforward, starting from the
conservation equations for protein and ligand:
½MT ¼ ½M1 2½M2Ln
½L
T
¼ ½L1 n½M2Ln; (4)
where M and L represents the protein monomer and the ligand molecule,
respectively. The global-equilibrium constant, K, governs the partition into
bound and free species:
K ¼ KLKd ¼ ½M2Ln½M2½Ln; (5)
where KL is the equilibrium constant for ligand binding, and Kd is the
dimerization constant for the protein. Therefore, Eq. 4 can be written in terms
of free concentrations:
½MT ¼ ½M1 2K½M2½Ln
½LT ¼ ½L1 nK½M2½Ln: (6)
The free concentration of protein, [M], can be calculated by solving
analytically the ﬁrst equation of the previous set:
FIGURE 10 Interaction between ecarpholin S and suramin, using ITC.
Raw thermal power signal (top) and plot of integrated heat versus ligand/
protein molar ratio (bottom). Conditions: 0.03 mM ecarpholin S titrated with
5-mL injections of 0.5 mM suramin. Both protein and suramin solutions
were in 50 mM Tris-HCl at pH 7.0 and 30C. In the analysis, protein
concentration was considered on a monomer basis (0.03 mM). Titration
curve was analyzed using a fully cooperative model in which n ligand
molecules (n ¼ 2, 3) bind to a protein dimer. Thermodynamic binding
parameters obtained are: K ¼ (2.1 6 0.6) 3 1020 (M4), DH ¼ 27 6
1 kcal/mol, N¼ 0.696 0.05 for n¼ 3 (dashed line); and K¼ (1.96 0.3)3
1014 (M3), DH ¼ 26.76 0.8 kcal/mol, N ¼ 1.096 0.05 for n ¼ 2 (solid
line).
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½M ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
11 8K½M
T
½Lnp  1
4K½Ln ; (7)
and it can be introduced into the second equation of the previous set, to
calculate the free-ligand concentration, [L]:
½L
T
¼ ½L1 nð
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
11 8K½MT½Ln
p  1Þ2
16K½Ln ; (8)
which can be solved numerically (e.g., by the Newton-Raphson method).
Once the free-ligand and free-protein concentrations are known, the con-
centration of the complex can be calculated from Eq. 5:
½M2Ln ¼ K½M2½Ln: (9)
The concentration of total ligand and total protein in the calorimetric cell after
each injection i is calculated as:
½LT;i ¼ ½L0 1 1
v
V
 i 
½MT;i ¼ ½M0 1
v
V
 i
; (10)
where [L]0 is the concentration of ligand in the syringe, [M]0 is the initial
concentration of protein in the cell, and v and V are the injection volume and
the cell volume, respectively. The factor (1  v/V) is the dilution factor after
each injection.
Given the total concentration of protein and ligand in the calorimetric cell
before and after each injection (Eq. 10), and assuming a certain value for the
equilibrium constant K, the concentration of free ligand and free protein,
before and after each injection, can be calculated by solving Eqs. 7 and 8, and
the concentration of the complex can be calculated from Eq. 9. Then the heat
qi associated with the injection i is calculated for the sequential ligand-
binding model:
qi ¼ VDH ½M2Lni  ½M2Lni1 1
v
V
  
1 qd; (11)
where DH is the global enthalpy (Eq. 3), and qd is the so-called ‘‘dilution
heat’’ (constant background heat effect due to unspeciﬁc phenomena such as
ligand dilution upon injection and injection turbulence). Nonlinear least-
square regression, using Eq. 11, will provide K and DH as adjustable
parameters. It is customary to include an additional parameter N (i.e., using
N[M]T instead of [M]T in all previous equations) to account for a different
stoichiometry than the one expected or a mismatch between the measured
concentrations and the actual ones.
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